Martin Hensel

Martin is the Founder of SelfRx Media and editor-in-chief of Type 2 Nation. He's passionate about sharing knowledge with people with Diabetes.

Treatment of Type2 Diabetes

Martin HenselApril 2, 2019
0 1,459

A1c Not Reliable in Diagnosing T2D

“Based on our findings, A1c should not be solely used to determine the prevalence of diabetes,” said lead researcher Maria…
Read More »
Treatment of Type2 Diabetes

Martin HenselMarch 27, 2019
0 1,932

Basal Insulin Management is not easy. This new tool could help

Lower Fasting Glucose When people with Type 2 Diabetes start basal insulin treatment, the goal is to reach a lower…
Read More »
Treatment of Type2 Diabetes

Martin HenselMarch 19, 2019
0 3,240

Prescription EPA Substantially Lowers Cardiovascular Risk in People with T2D

We spoke with Robert Busch, MD, an endocrinologist at Albany Medical Center about the REDUCE-IT cardiovascular risk reduction clinical trial…
Read More »
Treatment of Type2 Diabetes

Martin HenselMarch 12, 2019
0 2,538

iGlucose Is Simple, Affordable and Connected

We spoke with Cliff McIntosh, CEO of Smart Meter, which he has led since 2014, following success in other start-ups…
Read More »
Treatment of Type2 Diabetes

Martin HenselMarch 5, 2019
0 1,733

Hygieia Rewriting Advanced T2D Care!

We spoke with Eran Bashan, CEO, Co-founder, and Chairman of Hygieia based in Livonia, Michigan. See https://hygieia.com/ App is Small…
Read More »
Treatment of Type2 Diabetes

Jim Cahill and Martin HenselSeptember 5, 2017
0 3,093

Good News About GLP-1 Drugs and Cardiovascular Health

A popular non-insulin injectable drug that long ago met the FDA cardiovascular safety test can now claim a cardiovascular benefit.
Read More »
Treatment of Type2 Diabetes

Jim Cahill and Martin HenselSeptember 5, 2017
0 1,364

Weighing the Benefits of a Bariatric Procedure

When diet and lifestyle changes to combat obesity don’t work, surgical approaches and new generation devices can, but they all…
Read More »
Treatment of Type2 Diabetes

Jim Cahill and Martin HenselAugust 22, 2017
0 1,470

Janssen’s SGLT-2 Drugs and Risk of Amputations: What Happened, and What’s Next?

The European regulators have applied their amputation risk warning to all Janssen products in the SGLT-2 inhibitor class. But FDA…
Read More »
Treatment of Type2 Diabetes

Jim Cahill and Martin HenselJuly 31, 2017
0 1,449

Keeping Diabetic Eye Disease In Check

Here’s our reminder that you need to visit your eye doctor regularly to check for signs of diabetic retinopathy. We’re…
Read More »
Treatment of Type2 Diabetes

Jim Cahill and Martin HenselJuly 17, 2017
0 2,975

Having A Look At The American Diabetes Association’s 2017 Clinical Practice Update

Many T2D’s treat almost exclusively with the family doctor. The American Diabetes Association publishes an annual update of its clinical…
Read More »

Previous page Next page